VIGEO THERAPEUTICS
Vigeo Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutic agents intended to treat an advanced malignant tumor that can effectively treat multiple types of cancer and improve the lives of patients. The company building a first-in-class drug discovery pipeline that reprograms the tumor immune microenvironment (TIME). They plan to commence multiple combination studies to evaluate VT1021 in combination with chemotherapies and/or anti-PD-1 antibodies. The company was established in 2011 and is headquartered in Cambridge, Massachusetts.
VIGEO THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vigeotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
617-945-0385
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Content Delivery Network Sitelinks Search Box Microsoft Exchange Online Office 365 Mail
Similar Organizations
Cascadian Therapeutics
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Palatin Technologies
Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
Current Advisors List
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-21 | Vigeo Therapeutics Provides Clinical Update for Lead Asset VT1021 and Welcomes New Chief Executive Officer |
Official Site Inspections
http://www.vigeotherapeutics.com Semrush global rank: 2.4 M Semrush visits lastest month: 7.62 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
